Nanologica becomes strategic partner in €10M EU project to develop new treatments for tuberculosis

STOCKHOLM--(BUSINESS WIRE)--Nanologica's carrier materials play key part in the four-year EU project ORCHID. Led by GlaxoSmithKline (GSK), the €10 million project aims to discover and develop new medicines against tuberculosis.

Feed Date: 
February 15, 2012